Related Experiment Videos
Awareness, knowledge, attitude, and behaviors related to topical corticosteroid use among population in Hail, Saudi
Luluh Zamil Aljaloud1, Naif Altamimi1, Reem Marzouq S Alharthi2
1Dermatology Department, College of Medicine, University of Ha'il, Hail, Kingdom of Saudi Arabia.
Background:
Corticosteroids are widely used for inflammatory conditions, yet misuse and limited public awareness can cause preventable harm. In Hail, Saudi Arabia, community knowledge appears limited, warranting targeted assessment.
Objective:
To assess knowledge, awareness, attitudes, and use patterns of topical corticosteroids (TCSs) among adults in Hail, Saudi Arabia.
Methods:
We conducted a cross-sectional online survey (October 2024-March 2025) among adults aged ≥18 years. Of 535 respondents, 419 (78.0%) reported prior TCS use and were included in behavioral analyses, while 116 (21.0%) were non-users. Descriptive statistics summarized patterns, and bivariate analyses examined associations between awareness and behaviors.
Results:
Prescription use was more common than self-medication (58.9% vs 41.1%), and most users applied corticosteroids once daily (60.6%). Mometasone was the most frequently reported agent (33.9%), although 36.8% could not name the product; acne, melasma, and tinea were common indications. Awareness was moderate: 62.8% recognized potency categories, and 55.4% were aware of adverse effects. Overall, 45.0% reported ≥1 adverse effect, most often mood changes, pruritus, increased thirst/urination, or skin thinning. Most had discontinued at least once (79.5%); tapering was more frequent than abrupt cessation (58.9% vs 41.1%), and relapse occurred in 23.7%, often within a week. Awareness aligned with safer practice: aware users were more likely to have a prescription (65.0% vs 48.7%) and to recognize adverse effects (73.8% vs 24.4%); prescribed users also tapered more often than they stopped abruptly (67.6% vs 43.9%).
Conclusion:
TCS use is prevalent in Hail and is accompanied by self-medication and important knowledge deficits. Strengthening pharmacist counseling, improving labeling, regulating access to higher-potency agents, and implementing community education initiatives may enhance safety and reduce avoidable adverse outcomes.
Related Concept Videos
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
COPD: Management Using Bronchodilators and Corticosteroids
Cushing Syndrome II: Pathophysiology
Cushing Syndrome I: Introduction
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Adrenal Gland Disorders
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...